Your browser doesn't support javascript.
loading
Regression of EGFR positive established solid tumors in mice with the conditionally active T cell engager TAK-186.
Dettling, Danielle E; Kwok, Eilene; Quach, Lucy; Datt, Aakash; Degenhardt, Jeremiah D; Panchal, Anand; Seto, Pui; Krakow, Jessica L; Wall, Russell; Hillier, Brian J; Zhu, Ying; Vinogradova, Maia; DuBridge, Robert B; May, Chad.
Afiliação
  • Dettling DE; Oncology Drug Development Unit, Takeda Development Centers America, Inc (TDCA), Lexington, Massachusetts, USA danielle.dettling@alaunusbio.com.
  • Kwok E; Oncology Drug Development Unit, Takeda Development Centers America, Inc (TDCA), Lexington, Massachusetts, USA.
  • Quach L; Oncology Drug Development Unit, Takeda Development Centers America, Inc (TDCA), Lexington, Massachusetts, USA.
  • Datt A; Oncology Drug Development Unit, Takeda Development Centers America, Inc (TDCA), Lexington, Massachusetts, USA.
  • Degenhardt JD; Oncology Drug Development Unit, Takeda Development Centers America, Inc (TDCA), Lexington, Massachusetts, USA.
  • Panchal A; Oncology Drug Development Unit, Takeda Development Centers America, Inc (TDCA), Lexington, Massachusetts, USA.
  • Seto P; Oncology Drug Development Unit, Takeda Development Centers America, Inc (TDCA), Lexington, Massachusetts, USA.
  • Krakow JL; Oncology Drug Development Unit, Takeda Development Centers America, Inc (TDCA), Lexington, Massachusetts, USA.
  • Wall R; Oncology Drug Development Unit, Takeda Development Centers America, Inc (TDCA), Lexington, Massachusetts, USA.
  • Hillier BJ; Oncology Drug Development Unit, Takeda Development Centers America, Inc (TDCA), Lexington, Massachusetts, USA.
  • Zhu Y; Oncology Drug Development Unit, Takeda Development Centers America, Inc (TDCA), Lexington, Massachusetts, USA.
  • Vinogradova M; Oncology Drug Development Unit, Takeda Development Centers America, Inc (TDCA), Lexington, Massachusetts, USA.
  • DuBridge RB; Oncology Drug Development Unit, Takeda Development Centers America, Inc (TDCA), Lexington, Massachusetts, USA.
  • May C; Oncology Drug Development Unit, Takeda Development Centers America, Inc (TDCA), Lexington, Massachusetts, USA.
J Immunother Cancer ; 10(6)2022 06.
Article em En | MEDLINE | ID: mdl-35728872
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Receptores ErbB / Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Receptores ErbB / Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article